Treatment Pattern and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Did Not Receive Autologous Stem Cell Transplantation: A Real-World Observational Study : Treatment pattern and outcomes in patients with multiple myeloma.

Jianming HeLuke SchmeroldRian Van RampelberghLugui QiuRavi PotluriAnandaroop DasguptaLin LiYunan LiPeter HuSepideh NematSteven S SmugarPaul ZeltzerCarlos AppianiQing LiManeesha MehraUte Richarz

Published in: Advances in therapy (2020)

Results demonstrated that the frontline therapies prescribed to most patients who did not receive ASCT for MM in the United States were consistent with the NCCN guideline recommendations. Longer frontline treatment duration was associated with improved OS.

Keyphrases

stem cell transplantation
multiple myeloma
newly diagnosed
high dose
stem cells
low dose
mesenchymal stem cells
combination therapy
metabolic syndrome
clinical practice
replacement therapy
platelet rich plasma